Evidence map›Paper›PMID 40276599›Full record

ReviewFrontiers in pharmacology2025

Extraction, content determination, component analysis, and pharmacological action of Hedysari flavonoids: a review of research progress.

Cancan Huang, Haiyan Mao, Wenwen Wan, Chunzhen Ren, Xiujia Ji, Bin Yue, Xiaohua Zhang, Quansheng Wu

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Formononetin: pharmacological properties and therapeutic potential.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cancan Huang *Clinical School of Traditional Chinese Medicine, Gansu University of Chinese Medicine, Lanzhou, China.
Haiyan Mao *Department of Traditional Chinese Medicine, Gansu Provincial People's Hospital, Lanzhou, China.
Wenwen WanClinical School of Traditional Chinese Medicine, Gansu University of Chinese Medicine, Lanzhou, China.
Chunzhen RenSchool of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, China.
Xiujia JiClinical School of Traditional Chinese Medicine, Gansu University of Chinese Medicine, Lanzhou, China.
Bin YueClinical School of Traditional Chinese Medicine, Gansu University of Chinese Medicine, Lanzhou, China.
Xiaohua ZhangClinical School of Traditional Chinese Medicine, Gansu University of Chinese Medicine, Lanzhou, China.
Quansheng WuClinical School of Traditional Chinese Medicine, Gansu University of Chinese Medicine, Lanzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radix Hedysari is a traditional Chinese herbal medicine and food. It has a long history of clinical application and is used to improve health and treat various diseases. Hedysari polysaccharides, flavonoids, saponins, and alkaloids are the main components of Radix Hedysari. Hedysari flavonoids are the most important natural active ingredients in Radix Hedysari and have a variety of pharmacological effects. At present, Hedysari flavonoids have shown great application prospects in the development of drugs for the treatment of pulmonary fibrosis, osteoporosis, skeletal muscle injury, atherosclerosis, hepatic fibrosis, immune regulation, hypoglycemia, and renal fibrosis. This paper reviewed the extraction, separation, and content determination methods and chemical constituents of flavonoids from Radix Hedysari. The core electronic databases used for literature retrieval included Baidu Literature, Baidu Literature, WangFang Datas, CNKI, VIP Datas, PubMed, Google Scholar, and Web of Science. "

Indexed as

anti-osteoporosisanti-oxidationcontent determinationHedysari flavonoidsimprovement in fibrosisstructural analysis

Identifiers

PMID40276599
PMCPMC12018343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.